Study of b lymphocyte subpopulations in the peripheral blood and cephalorraquidian liquid of patients with primary progressive multiple sclerosis
http://repositorio.unicamp.br/handle/REPOSIP/345646
Abstract:
B lymphocytes actively participate in the pathogenesis of Multiple Sclerosis (MS). The autoantibodies produced by these cells can cause tissue damage in neurons, contributing to neurodegeneration.
B lymphocytes are more efficient antigen presenting cells when compared to other cells, since the neuroantigen is specifically recognized by the B lymphocyte antigen (BCR) receptor, processed and presented to autoreactive CD4 + T lymphocytes, also contribute to the pathogenesis of MS through the production of auto antibodies, in the presentation of neuro-antigens to CD4 + T lymphocytes and synthesis of pro-inflammatory cytokines that amplify the effective response of T lymphocytes.
Furthermore, T lymphocytes produce pro and anti-inflammatory cytokines that amplify or reduce the inflammatory response. Tertiary lymphoid tissues where B lymphocytes predominate have been described in the meninges of patients with MS in primarily progressive (EMPP) and secondarily progressive (EMSP) forms. In this study, we showed the increase in cytotoxic B lymphocytes in peripheral blood and the presence of these cells in the cerebrospinal fluid of patients with primarily progressive MS.
The increase in cytotoxic B lymphocytes is associated with an increase in the Runx3 transcription factor. In addition to the increase in cytotoxic B lymphocytes, there was a significant increase in neurofilaments in the cerebrospinal fluid of patients with PPMS and a decrease in serum levels of cerebral neurotrophic factor (BDNF).
This evidence shows that the cytotoxicity of B lymphocytes can contribute to neurodegeneration in progressive forms of MS
cytotoxic B lymphocytes
A forum to discuss research on the origins of MS and its development.
Return to “MS Etiology and Pathogenesis”
Jump to
- Multiple Sclerosis
- ↳ General Discussion
- ↳ Introductions
- ↳ Drug Pipeline
- ↳ Regimens
- ↳ Undiagnosed
- ↳ MS Etiology and Pathogenesis
- Treatments
- ↳ Chronic Cerebrospinal Venous Insufficiency (CCSVI)
- ↳ Low Dose Naltrexone
- ↳ Tysabri (Antegren, Natalizumab)
- ↳ Copaxone
- ↳ Glatopa
- ↳ Avonex
- ↳ Rebif
- ↳ Betaseron
- ↳ Plegridy
- ↳ Novantrone
- ↳ Aimspro
- ↳ Diet
- ↳ Stem Cells
- ↳ Antibiotics
- ↳ Campath (Lemtrada, Alemtuzumab)
- ↳ Gene Therapy
- ↳ Natural Approach
- ↳ Biotin (Qizenday, Cerenday, MD1003)
- ↳ Coimbra High-Dose Vitamin D Protocol
- ↳ Statins
- ↳ Tcelna (Tovaxin)
- ↳ Revimmune (Cyclophosphamide, Cytoxan)
- ↳ Medical Devices
- ↳ Rituxan (Rituximab)
- ↳ Ocrevus (Ocrelizumab)
- ↳ Kesimpta (Ofatumumab)
- ↳ Briumvi (Ublituximab-xiiy)
- ↳ General Medications
- ↳ Tecfidera (BG-12, Dimethyl fumarate)
- ↳ Vumerity (Diroximel fumarate)
- ↳ Bafiertam (Monomethyl fumarate)
- ↳ Gilenya
- ↳ Aubagio (Teriflunomide)
- ↳ Mayzent (Siponimod)
- ↳ Zeposia (Ozanimod)
- ↳ Ponvory (Ponesimod)
- ↳ Mavenclad (Cladribine)
- ↳ Ampyra (Dalfampridine)
- ↳ Medical Marijuana
- ↳ Sativex
- ↳ Chiropractic Treatment
- Life
- ↳ Daily Life
- ↳ Veterans and MS
- ↳ Trigeminal Neuralgia in MS
- ↳ Reading Nook
- ↳ Humor
- ↳ Shopping
- ↳ Friends and Family
- ↳ Mental & Spiritual Health
- ↳ Exercise and Physical Therapy
- ↳ Under 25 with MS
- ↳ MS in the Golden Years
- ↳ Parenting Kids With MS
- ↳ Parents with MS
- ThisIsMS.com
- ↳ Site Support
- ↳ Suggestions